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aims: Some central nervous system pathogens express neuraminidase (NA) on their 
surfaces. In the rat brain, a single intracerebroventricular (ICV) injection of NA induces 
myelin vacuolation in axonal tracts. Here, we explore the nature, the time course, and the 
role of the complement system in this damage.
Methods: The spatiotemporal analysis of myelin vacuolation was performed by optical 
and electron microscopy. Myelin basic protein-positive area and oligodendrocyte tran-
scription factor (Olig2)-positive cells were quantified in the damaged bundles. Neuronal 
death in the affected axonal tracts was assessed by Fluoro-Jade B and anti-caspase-3 
staining. To evaluate the role of the complement, membrane attack complex (MAC) 
deposition on damaged bundles was analyzed using anti-C5b9. Rats ICV injected with 
the anaphylatoxin C5a were studied for myelin damage. In addition, NA-induced vacu-
olation was studied in rats with different degrees of complement inhibition: normal rats 
treated with anti-C5-blocking antibody and C6-deficient rats.
results: The stria medullaris, the optic chiasm, and the fimbria were the most consis-
tently damaged axonal tracts. Vacuolation peaked 7 days after NA injection and reverted 
by day 15. Olig2+ cell number in the damaged tracts was unaltered, and neurode-
generation associated with myelin alterations was not detected. MAC was absent on 
damaged axonal tracts, as revealed by C5b9 immunostaining. Rats ICV injected with 
the anaphylatoxin C5a displayed no myelin injury. When the complement system was 
experimentally or constitutively inhibited, NA-induced myelin vacuolation was similar to 
that observed in normal rats.
conclusion: Microbial NA induces a moderate and transient myelin vacuolation that is 
not caused either by neuroinflammation or complement system activation.
Keywords: anti-c5, brain, c5a, c6-deficient rats, complement system, myelin vacuolation, neuraminidase, 
neuroinflammation
2Granados-Durán et al. NA Induces Myelin Vacuolation
Frontiers in Neurology | www.frontiersin.org March 2017 | Volume 8 | Article 78
inTrODUcTiOn
Myelin disorders range from spontaneous inherited to acquired 
due to inflammatory processes, autoimmune disorders, infec-
tious processes, and toxic substances (1). Myelin vacuolation 
is the most frequent pathologic feature of myelin sheaths 
(1–3), although it should be differentiated from neuronal 
vacuolation that occurs in some encephalopathies such as 
bovine spongiform encephalopathy (4). The idea that myelin 
vacuolation is equivalent to myelin degeneration is not exact, 
since some pathologies, such as Canavan’s disease, display a 
conspicuous myelin vacuolation with mild demyelination 
(1). Myelin vacuolation may occur in at least two ways, the 
most frequent of which is intramyelinic vacuolation. This is 
produced when the myelin lamellae split along the intraperiod 
line, which in turn reopens the extracellular space initially 
closed during the formation of myelin (5, 6). This mechanism 
can generate vacuoles (filled with unstainable material) at mul-
tiple levels within the myelin sheath and has been associated 
with fluid accumulation in the nervous system parenchyma 
(6). Vacuolation can be caused by inherited conditions (7), as 
is the case in Canavan’s disease (8), or by the effects of toxins 
(9–12). The other mechanism of myelin vacuolation occurs 
when the lamellae split at the major dense line, thus reopening 
the intracellular space of the oligodendrocyte or the Schwann 
cell (6). Whatever the etiology of vacuole formation, the 
progression from myelin vacuolation to demyelination may 
depend on whether the primary defect or target is the myelin 
sheath or the myelinating cells, and on the time of exposure to 
the inducing agent (1).
Gangliosides are sialic acid-containing glycosphingolipids 
located in the outer leaflet of the plasma membrane, which bear a 
glycan moiety extending out into the extracellular side (13). The 
myelin-associated glycoprotein (MAG), a transmembrane glyco-
protein specific for myelinating cell membranes (14), specifically 
binds to axonal gangliosides through the terminal α2,3-linked 
sialic acid (15–17). Affinity studies showed that MAG binds 
preferentially to GD1a and GT1b (15), the latter present in white 
matter. In the central nervous system (CNS), MAG is located 
only on the innermost wrap of myelin, in direct contact with the 
axonal surface (18); this location has endorsed its involvement in 
axon–myelin recognition (19).
Neuraminidase (NA) is an exo-glucosidase that removes 
terminal sialic acid from glycan chains, preferably those joined 
by α2,3 linkages (20). It has been reported that some of the 
viruses associated with subsequent myelin disorders contain NA 
in the coat. A single intracerebroventricular (ICV) injection of 
Clostridium perfringens NA within the lateral ventricle (LV) of 
rats induces a partial ependymal denudation that affects mainly 
the ipsilateral ventricle with minimal spread to the contralateral 
and third ventricles (21–23). Recently, the neuroinflammatory 
events triggered by NA ICV injection have been described (24), 
and the participation of the complement system in ependymal 
cell death by NA has been demonstrated (25). However, although 
the vacuolation of some axonal tracts has been described (23, 24), 
a detailed study of such alterations in the axonal tracts had not 
been performed.
The role of the complement system in some demyelinat-
ing disorders is an issue of debate and the precise function of 
complement in such processes remains elusive (26). So, while 
some reports speak about a protective role of complement in 
demyelinating processes (27, 28), others point to its involvement 
in immune-mediated myelin diseases (29–34), or even its lack of 
participation (35). In neuromyelitis optica, an autoimmune dis-
ease of the CNS displaying intramyelinic edema and tissue vacu-
olation, the complement activation is observed in damaged tissue 
(36). On the other hand, several facts suggest the participation 
of the complement system in NA-induced myelin vacuolation: 
(i) sialic acid removal from human tumor cells and red blood 
cells makes them susceptible to alternative pathway activation 
and formation of the membrane attack complex (MAC) (37, 38); 
(ii) NA can directly activate the alternative complement pathway 
(39); and (iii) the presence of NA within the cerebral ventricles 
triggers the activation of the complement system which contrib-
utes to ependymal disruption (25).
The present report describes the spatial distribution and the 
time course of the myelin vacuolation induced by intraventricu-
lar NA. Damage to myelin sheaths, oligodendrocyte cells, and 
neurons were assessed. Furthermore, the role of the complement 
system was investigated by injecting the anaphylatoxin C5a in the 
ventricles of normal rats, and also by the administration of NA 
to two rat models in which the complement system is disturbed.
MaTerials anD MeThODs
animals
Adult male Wistar rats (7 weeks old) with 250–300 g body weight 
(Charles River Laboratories, Barcelona, Spain) were used in this 
study. In addition, a strain of rats deficient in the C6 component 
of complement, where the formation of the MAC is blocked (32, 
40), was used as well. Between five and six animals were used 
for each time or experimental situation involving NA injection 
(unless otherwise indicated), while only three animals were 
used as control rats. All animals were housed under a 12-h light/
dark cycle with food and water available ad  libitum. Animal 
procedures were performed according to the European Union 
(86/609/EEC) and Spanish (RD 1201/2005) legislations. Animal 
care and experimental procedures were approved by the Animal 
Experimentation Ethics Committee of the Universidad de Málaga 
(ref. number 2012-0013).
icV injection
Animals were anesthetized with 2,2,2-tribromoethanol (0.2 g/kg 
bw, Fluka Chemika) and positioned in a stereotaxic frame. NA 
from C. perfringens (Roche Diagnostics, 11 585 886 001) dissolved 
in 0.9% sterile saline (25 mU/μl) was administrated by stereotaxic 
surgery into the right lateral cerebral ventricle. The coordinates 
from Bregma used were antero-posterior −0.5 mm, medio-lateral 
−1.4 mm, and dorso-ventral −3.5 mm. A single dose of 500 mU 
(20 μl) of NA was injected with the aid of a pump at a rate of 
2 μl/min over 10 min. Some animals were sacrificed immediately 
after NA injection (time 0 h), and the rest were recovered from 
anesthesia and sacrificed at 2 h, 4 h, 12 h, 24 h, 2 days, 4 days, 
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7 days, 15 days, and 30 days after the administration of NA. For 
each time, three control rats were ICV injected with saline and 
processed. In order to know whether the neuroinflammatory 
reaction itself could induce the myelin vacuolation, four rats 
were ICV injected with the anaphylatoxin C5a (5 μg/20 μl; Sigma-
Aldrich ref. C5788), which generates a severe neuroinflammation 
(41). These animals were sacrificed 24 h after the C5a injection 
and processed for histological studies. Although similar experi-
ments have been carried out in previous studies (41), the location 
of vacuolization at very specific sites, as it is in our NA-injected 
rats, could have gone unnoticed.
inhibition of the complement component 
c5
In order to obtain both systemic and ventricular inhibition of 
complement component C5, a strategy consisting of the injection 
of a blocking anti-rat C5 monoclonal antibody [C5-inh; clone 
18A10, Alexion Pharmaceutical, Inc. (42, 43)] was employed. 
Four animals were used in this experiment. The regimen of anti-
C5 administration was as previously described (44); an initial 
intravenous injection (20 mg/kg bw) was followed 6 h later by 
an intraperitoneal injection (10  mg/kg bw). According to the 
published data (44), this protocol resulted in a 50–60% inhibi-
tion of C5 activity for up to 12 h after the first injection, with the 
highest inhibition occurring about 1 h after the second injection. 
At this time of maximal systemic inhibition, the antibody was 
also injected ICV to guarantee the inhibition of C5 within the 
ventricular system. In those animals treated with anti-C5 and NA, 
both were ICV injected simultaneously (20 μl of a mixture of NA 
25 mU/μl and C5-inh 0.38 μg/μl) following the same parameters 
outlined above. After 7 days of this treatment, rats were perfused 
and the brains processed for histological and immunocytochemi-
cal studies.
histological Procedures
Animals were anesthetized with 2,2,2-tribromoethanol and tran-
scardially perfused with saline followed by Bouin’s fixative (45). 
Brains were removed and immersed in the same fixative for 24 h, 
and later embedded in paraffin wax. Seven-micrometer sections 
were obtained from each brain and mounted on poly-l-lysine-
treated slides. Series of sections along the brain region of interest 
(from Bregma −0.3 to −1.2 mm approximately) were obtained. 
Hematoxylin–eosin staining was applied to counterstain the 
sections.
immunohistochemistry
Immunohistochemistry was carried out on deparaffinized tissue 
sections using the immunoperoxidase technique. The primary 
antibodies used were as follows: rabbit anti-rat C5b-9 (1:200, 
Abcam, ab55811); rabbit anti-rat C9 (1:100, provided by Prof. B. 
P. Morgan, Cardiff University); rabbit anti-myelin basic protein 
(MBP) (1:500, Zymed, 18-0038); goat anti-Olig2 (1:100, RyD 
System, AF2418); and mouse anti-caspase-3 (1:100, Thermo, 
MS1123R7). The secondary antibodies used were as follows: 
biotinylated goat anti-rabbit IgG (H + L) (1:1,000, Pierce, 31820); 
biotinylated horse anti-goat IgG (H + L) (1:1,000, Vector, BA9500). 
For the mouse antibody against caspase-3, the Ultravision Quanto 
HRP system (Thermo Fisher Scientific, TL060QHD) was used. 
All antibodies were diluted with PBT buffer (0.3% bovine serum 
albumin, 0.3% Triton X-100 in PBS pH 7.3). Primary antibodies 
were incubated overnight at room temperature (RT). Secondary 
antibodies were incubated for 60 min at RT. Negative controls for 
the immunostaining consisted of equivalent sections subjected to 
the same protocol but omitting the primary antibody.
Prior to the overnight incubation with the primary antibody, 
the sections stained with the immunoperoxidase procedure were 
incubated in 3% hydrogen peroxide and 10% methanol in PB 
0.1  M to quench endogenous peroxidase activity. In such sec-
tions, biotinylated secondary antibody was used, along with the 
avidin–biotin complex (ABC) amplification method. The ABC 
reagent was prepared according to the manufacturer’s instructions 
(Thermo Fisher Scientific) and incubated for 30 min. Peroxidase 
activity was revealed with 0.05% DAB and 0.03% hydrogen per-
oxide. All the incubations were performed in a moist chamber 
at RT. Hematoxylin–eosin or only hematoxylin was used to 
counterstain some immunostained sections; however, it was not 
used with a weak immunostaining (as anti-C5b9) or to quantify 
oligodendrocytes.
electron Microscopy
Three ICV NA-injected rats were perfused with Karnovsky’s fixa-
tive (46). Once extracted, the brains were kept in the same fixative 
overnight at 4°C. Vibratome sections (200 μm thick) were used to 
obtain pieces (3 mm × 3 mm) of different brain areas. These were 
post-fixed in 2% osmium tetroxide (in 0.1 M phosphate buffer, 
1 h at 4°C), dehydrated in graded alcohol series, and embedded in 
Araldite resin (Grade 502, Sigma-Aldrich, ref. AR502). Ultrathin 
sections (50–70 nm thick) were obtained with an ultramicrotome 
(Leica, EM UC7) using a diamond knife (Diatome, Ultra 45°). 
Sections were contrast stained with lead citrate and uranyl 
acetate, and analyzed using a transmission electron microscope 
(Geol JEM-1400, 80 kV). Electron micrographs were taken with 
a digital camera (Gatan, ref. ES1000W). Sectioning and ultrathin 
observation were performed at the electron microscopy core 
facility at Universidad de Málaga.
Fluoro-Jade B staining
Fluoro-Jade B is a polyanionic fluorescein derivative that specifi-
cally binds to degenerating neurons (47), regardless of whether 
the death is through necrosis or apoptosis. This compound has 
an excitation peak at 480 nm and an emission peak at 525 nm. 
Sections from five rats (12 h after NA treatment) were deparaffi-
nized and hydrated in alcohols in the conventional manner, but 
including a 5-min step in 80% ethanol with 1% NaOH. Then, 
the sections were incubated in 0.06% potassium permanganate 
solution (10 min), washed with distilled water (2 min), and then 
incubated with a 0.0004% solution of Fluoro-Jade B in 0.1  M 
acetic acid solution (20  min). The sections were then washed 
with distilled water (3× 1 min) and air dried 10 min, and further 
dried on a hotplate at 50°C for 10 min. Once dried, they were 
immersed in xylene for 5 min and mounted with Eukitt®. This 
staining was applied to Bouin’s-fixed paraffin sections. Sections of 
the cortical region directly damaged by the injection needle were 
used as positive control.
FigUre 1 | intracerebroventricular (icV) injection of neuraminidase 
(na) induces vacuolated lesions in axonal bundles. (a) Sagittal scheme 
of the rat brain illustrating the coronal levels studied: continuous line 
[AP = −1.0 mm; (B–D)] and discontinuous line [AP = −0.3 mm; (e,F)].  
(B) Coronal section of a rat brain 7 days after ICV injection of NA. (c) Detail 
of the fimbria (Fi) in the injected ventricle with vacuolar lesions (arrows).  
(D) Detail of the contralateral fimbria without alterations. (e) Detail of the SM 
(area outlined with the dotted line) presenting abundant vacuoles (arrows).  
(F) Ipsilateral ventricular region with vacuolar lesions (arrows) in the septum. 
Inset in panel (F): scheme of a coronal brain section framing the area showed 
in panel (F). All sections were stained with hematoxylin and eosin (H–E). Bv, 
blood vessel; CC, corpus callosum; Cg, cingulated; CP, choroid plexus; Ep, 
ependymal; III-V, third ventricle; LSN, lateral septal nucleus; LV, lateral 
ventricle; SM, stria medullaris; SO, subfornical organ. Magnification 
bar = 400 μm in panel (B), 60 μm in panels (c–e), and 200 μm in panel (F).
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Quantification of Myelin Vacuolation
In order to assess the time course of myelin vacuolation in 
NA-injected rats, MBP immunoreactivity was quantified in ipsi-
lateral and contralateral areas of animals sacrificed at different 
times postinjection (0 h, 1 day, 2 days, 4 days, 7 days, 15 days, 
and 30 days). Three sections from each animal (n = 4) (Bregma 
−0.92, −0.95, and −0.99 mm approximately) were chosen for the 
quantification. In any case, the selected sections were close to the 
foramen of Monro but far enough from the site of injection as to 
avoid areas of surgically damaged tissue. Such sections contained 
areas of interest including the stria medullaris (SM) and the optic 
chiasm. However, the fimbria was not analyzed because it is too 
close to the injection site and could be affected by the damage of 
the needle. From each histological section, two photographs were 
taken: one in the SM and another in the optic chiasm, both in the 
ipsilateral side. Photographs were always taken under the same 
conditions. Pictures were then processed using the image analysis 
software Visilog 6.3 (Noesis, France) to determine the propor-
tion of MBP-positive area per image. Afterward, the mean value 
was obtained from the three sections studied from each animal, 
which was considered the percentage of MBP-stained area of that 
animal. A total of five animals were analyzed at each postinjection 
time studied. By using such methodology, the higher vacuolation, 
the less percentage of MBP-stained area.
Quantification of Oligodendrocytes
A quantitative method was used to determine whether oligoden-
drocytes were damaged in the NA-treated rats. The oligodendro-
cyte immunocytochemical marker Olig2 (48) was applied on the 
same animals used for the semiquantification of MBP. From each 
animal (n =  4), four sections (spaced 70 μm apart) within the 
region of the foramen of Monro (between rostrocaudal Bregma 
levels −0.85 and −1.13 mm) were employed. Two photographs, 
one from the SM and other from the optic chiasm, were taken 
from each section using the 40× objective lens. The Olig2-positive 
cells were counted and referred to the quantified area. The aver-
age value was obtained from the four sections studied from each 
animal. Five animals were analyzed for each postinjection time 
studied.
statistical analysis
Differences between times postinjection of NA were evaluated by 
ANOVA (significance level of 0.05), followed by a Tukey post hoc 
test with a level of significance of 0.05. The Shapiro–Wilk test was 
used to ensure that the data met the criteria of normality to allow 
the use of parametric statistics. The Levene’s test was performed 
before the ANOVA to test the equality of variances. The values 
measured at time 0 were considered the baseline. The software 
SPSS® Statistics 20 (IBM®) was used for this analysis.
resUlTs
spatial Distribution and Time course of 
Myelin Vacuolation in na-injected rats
In brain sections stained with hematoxylin–eosin, vacuolar or 
spongiform areas were evident in different brain regions 7 days 
after the ICV injection of NA, although occasionally such 
alterations could be observed as early as 48 h. The affected zones 
corresponded to myelinated axonal tracts lying near the injected 
ventricle, such as the fimbria–fornix (Figures 1B–D) and the SM 
(Figure 1E), as well as more distant myelinated tracts, including 
the optic chiasm (Figure  5G). These tracts were consistently 
affected in all NA-treated rats, and the vacuoles correspond to 
the space generated adaxonally in some myelinated axons, as 
could be observed by electron microscopy (see below). Myelin 
vacuolation was mostly ipsilateral to the injection site, although 
as it extended along the tract it was sometimes possible to observe 
mild vacuolization in decussated tracts at the contralateral side.
Vacuolated areas were analyzed by transmission electron 
microscopy in order to explore the ultrastructural features of 
the holes. While control animals displayed axons with uniform 
and regular myelin sheaths, in the NA-injected rats some 
dilated and irregularly shaped myelin sheath were observed in 
transverse sections of the SM (Figure  2E, dotted line encloses 
one myelinated axon). Such dilated myelin sheath displayed an 
inner cavity, probably corresponding to the vacuoles observed by 
conventional histological techniques. Despite its larger diameter, 
the dilated myelin sheaths themselves were apparently similar to 
that observed in non-affected axons, or in axons from untreated 
FigUre 2 | Transmission electron microscopy of the myelin vacuolar 
lesions. (a) Stria medullaris (SM) from a normal rat, where myelinated axons 
display uniform and well packed myelin sheaths. (B–e) SM from 
neuraminidase-injected rats 7 days postinjection. In these animals, wide 
empty spaces (asterisk) that are surrounded by a myelin sheath can be 
observed. Such cavities are largely free of electrodense material, and an axon 
can be found inside (arrows). Such spaces most probably correspond to the 
vacuoles described by conventional histology. One of these cavities is 
outlined with a dashed line in panel (e). Oligodendrocyte cells [arrowheads in 
panel (B)] display an apparently normal morphology. (F) Abnormal myelinated 
axon with a disorganized myelin sheath (asterisk). Bv, blood vessel. 
Magnification bar = 5 μm in panels (a,B), 2 μm in panels (c–e), and 1 μm in 
panel (F).
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rats. Within the vacuoles, an axon was consistently found, par-
tially in contact with the myelin sheath (arrows in Figures 2C–E). 
Therefore, the cavity seems to arise from the space between the 
axonal surface and the innermost myelin wrap. Rarely axons 
showing a disorganized myelin sheath were found (asterisk in 
Figure 2F). These images are compatible with a partial disruption 
of the interaction between the innermost lamella of myelin and 
the axonal membrane.
Concerning the time course, myelin vacuolation reached a peak 
between 4 and 7 days postinjection of NA (compare Figure 3A 
with Figure  3B). However, from day 15 on, the number and 
the size of the holes were significantly reduced (Figures 3C,D), 
and 30 days after the NA injection, they were completely absent 
(Figure 3D). After 30 days, the SM and the fornix as well as the 
farthest myelinated tracts (e.g., the optic chiasm) were undis-
tinguishable from those of non-injected rats, with a uniform 
hematoxylin–eosin staining and the absence of cavities.
immunohistochemical analysis of the 
Myelin Vacuolation
The percentage of MBP-positive area was estimated at various 
postinjection times (1, 2, 4, 7, 15, and 30 days) in two consist-
ently vacuolated areas: the SM and the optic chiasm (Figure 4D). 
From the second day after treatment, MBP-positive area tended 
to decrease in the two regions studied (Figure 4D), and at day 
7, such reduction was significant compared to control MBP 
levels (0 days). From day 7 on, MBP-positive area progressively 
recovered, and by day 15, it was similar to that of non-treated rats 
(Figure 4D).
Olig2-positive cells were quantified in the SM and the optic 
chiasm at different times postinjection of NA (Figure 4G), but 
no significant variations were found at any of the times analyzed, 
not even at 7 days when vacuolation reached a peak. These results 
indicate that the number of oligodendrocytes was not modified 
by the treatment.
cell Death analysis in Vacuolated axonal 
Bundles
Fluoro-Jade B binds specifically to degenerating neurons 
undergoing necrosis or apoptosis. As a positive control, we used 
sections of the dorsal frontal cortex containing neurons mechani-
cally damaged due to the injection procedure (Figure  5A). 
While these control neurons displayed the fluorescent staining 
(Figure 5A), no other neuronal degeneration event was detected 
at any time analyzed or in any of the regions studied, which 
included the myelinated tracts consistently affected by vacuola-
tion (Figures 5B,C,F,G) and those areas projecting axons to the 
vacuolated bundles, such as the habenula or the hippocampus 
(Figures 5D,E). CASP3-positive cells were found in the subven-
tricular neurogenic zone in all animals (Figures 6A,B), highlight-
ing the normal apoptosis that occurs in the neurogenic niche. 
However, no other CASP3-positive cell was detected in any of 
the regions studied, i.e., the damaged ependymal epithelium of 
the injected ventricle (Figure 6D), and myelinated tracts typically 
affected by degeneration, such as the SM (Figure 6C). Ependymal 
cells were negative since they die by necrosis.
role of the complement system in the 
Vacuolation Process
To unravel whether activation of complement might be involved 
in the vacuolation process observed in NA-injected rats, several 
experimental approaches were performed: (i) immunolocaliza-
tion of the MAC on vacuolated bundles, (ii) ICV injection of the 
anaphylatoxin C5a in normal rats, and (iii) ICV injection of NA 
in two different rat models in which the complement system is 
inhibited.
None of the antibodies against MAC (anti-C5b9 and anti 
C9) revealed a positive labeling in any of the vacuolated axonal 
bundles studied (Figures 7A,C), thus suggesting the absence of 
FigUre 3 | Time course of myelin vacuolation in the sM after a single intracerebroventricular injection of neuraminidase. (a) One day after the 
treatment no vacuolation is observed. (B) At day 7, the density of vacuoles reaches a peak. (c) At day 15, most vacuoles have disappeared. (D) After 30 days, the 
SM (and other axonal bundles) recovers its normal appearance. All sections were stained with hematoxylin and eosin (H–E). SM, stria medullaris. Magnification 
bar = 100 μm in panels (a–D).
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MAC deposition on vacuolated tracts. Swollen lymph nodes were 
used as a positive control for anti-C5b9 (inset in Figure 7B).
In spite of the conspicuous neuroinflammation caused by the 
ICV injection of C5a, the tracts that regularly suffer vacuolation 
upon NA injection (i.e., SM, fimbria–fornix, and optic chiasm) 
appeared completely normal in C5a-injected rats.
In animals under MAC inhibition with anti-C5, the myelin 
vacuolization was similar to that observed in “non-inhibited” rats 
(Figures 7F,G). In C6−/− rats, the ICV injection of NA induces a 
vacuolation similar to that observed in normal rats injected with 
NA (Figures  7H,I). Therefore, the absence of MAC does not 
prevent the myelin vacuolation induced by NA. It could be hence 
concluded that complement MAC is not involved in the etiology 
of myelin vacuolation in this particular model.
DiscUssiOn
In the previous studies, a single ICV injection of a high dose of 
NA in the LV of rats resulted in the prompt and extensive death 
of ependymal cells, followed by an inflammatory reaction, myelin 
vacuolation, and long-term hydrocephalus (23). These severe 
effects were lessened by the administration of lower doses of NA, 
which resulted in neuroinflammation, a partial loss of ependymal 
cells, and myelin vacuolation (24). Recently, the implication of 
the complement system in NA-induced ependymal death has 
been reported (25). Here, we examined the noticeable alterations 
provoked by NA in some axonal tracts and the possible implica-
tion of the complement system.
The administration of NA in the LV elicited damage in 
multiple axonal tracts; those consistently affected were the fim-
bria–fornix complex, the SM, and the optic chiasm, all them on 
the ipsilateral side. Several factors could account for the recurrent 
damage of these particular axonal tracts: (i) their proximity to 
the ventricular surface or to the pial surface; (ii) their vicinity to 
the site of the ICV injection, and (iii) the way cerebrospinal fluid 
(CSF) distributes NA within the ventricular system. NA injected 
in the LVs reaches the brain parenchyma up to about 400 μm 
distance from the ependymal surface or the pial surface (22, 49). 
Therefore, NA may directly act on the axonal tracts close to the 
site of injection.
The affected axonal tracts displayed numerous vacuoles 
between days 4 and 7 after NA injection, when vacuolation 
reaches its peak (the MBP-stained area is the lowest). However, 
several facts suggest that the alterations triggering myelin vacu-
olation may be only moderate: (i) most of the vacuoles disappear 
15  days after the NA injection suggesting the repair of the 
damaged axonal bundles; (ii) transmission electron microscopy 
showed that the vacuoles appear between the axonal membrane 
and the innermost wrap of myelin (adaxonal vacuolation), while 
an apparently normal myelin sheath was observed; (iii) oligo-
dendrocyte number was not affected in the vacuolated axonal 
bundles; and (iv) neither neuronal degeneration nor neuronal 
apoptosis was observed in neuronal nuclei related to the damaged 
axonal bundles.
Concerning the etiology of the vacuoles, it is well established 
that myelin vacuolation can occur by at least two ways: (i) split 
along the intraperiod line, called intramyelinic vacuolation, 
which opens the extracellular space between myelin lamellae or 
between the axon membrane and the myelinating cells, and (ii) 
split of lamellae at the major dense line, which opens the intra-
cellular space of the oligodendrocyte or the Schwann cell (5, 6). 
Intramyelinic vacuolation results in vacuoles located at multiple 
levels within the myelin sheath or between the axonal membrane 
and the innermost wrap of myelin, and it has been associated with 
the accumulation of fluid that is non-stainable by conventional 
histological methods (6). The vacuolation triggered by NA likely 
represents intramyelinic vacuolation, since the vacuoles are pref-
erentially located between the myelin and the axonal membrane.
Myelin-associated glycoprotein is a transmembrane glyco-
protein member of the siglec family of sialic acid-binding pro-
teins (50, 51), which is specific for myelinating cell membranes 
(14). MAG is only present in the innermost wrap of myelin (18), 
suggesting a functional role in axon–myelin interactions (52). 
On the other hand, complex gangliosides displaying terminal 
α2,3-linked sialic acid (GT1b and GD1a) are present in the 
FigUre 4 | Time course of vacuolation and oligodendrocyte density in the sM and optic chiasm of neuraminidase (na)-injected rats. (a) Transverse 
section at the level of the foramina of Monro immunostained with anti-myelin basic protein (MBP). (B,c) The NA-injected ipsilateral fimbria (B) displays numerous 
vacuoles compared with the equivalent contralateral area (c). (D) The MBP-positive area was quantified in the ipsilateral SM and optic chiasm at several times after 
NA injection. The lowest MBP-positive area (corresponding to the highest level of vacuolation) was measured at 7 days postinjection in both the SM and the optic 
chiasm. (e,F) The ipsilateral (e) and contralateral (F) SM were immunostained with anti-Olig2 to quantify the number of oligodendrocytes in these axonal tracts.  
(g) Olig2-positive cells were counted in the ipsilateral side of both the SM and in the optic chiasm. No significant differences were found between the different 
postinjection times analyzed. The graph represents the mean ± SEM. Values at different times were compared by one-way ANOVA and a Tukey post hoc analysis. 
**P < 0.01; ***P < 0.001 compared to time 0 days. Sections in panels (a–c) were counterstained with hematoxylin and eosin (H–E). CP, choroid plexus; LV, lateral 
ventricle; SM, stria medullaris. Magnification bar = 400 μm in panel (a), 60 μm in panel (B), and 100 μm in panels (e,F).
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neuronal membranes (53), and GT1b is the only one which both 
strongly binds to MAG and is present in white matter (15, 53). 
Pretreatment of gangliosides with NA abolished the adhesion 
of MAG to either GT1b or GQ1b alpha (15, 54), indicating that 
ganglioside–MAG interaction is dependent on terminal sialic 
acid (55). Therefore, we hypothesize that the sialidase activity of 
NA may disrupt MAG–ganglioside recognition and hence the 
axon–myelin interaction, thereby promoting the onset of the 
adaxonal vacuolation. NA cytotoxic effects cannot be ruled out 
in the process. Such mechanism of vacuolation should give rise 
FigUre 5 | neuronal degeneration determined by Fluoro-Jade B staining 1 day after intracerebroventricular (icV) injection of neuraminidase.  
(a) Neuronal degeneration displaying green fluorescence (arrows) was revealed by Fluoro-Jade B in the cerebral cortex at the site of ICV injection, a region used as 
a positive control of the technique. (B–g) However, no fluorescent cells were detected in any area of the brain analyzed: (B) stria medullaris, (c) septum,  
(D) hippocampus, (e) cerebral aqueduct, (F) fimbria of the hippocampus, and (g) optic chiasm. Arrows in panel (g) point to vacuoles in the optic chiasm. Insets in 
panels (e,F): schemes of coronal brain sections framing the areas shown in the photographs. Magnification bar = 100 μm in panels (a,B), 75 μm in panel (c), 
200 μm in panel (D), 150 μm in panel (e), 70 μm in panel (F), and 50 μm in panel (g).
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to myelin abnormalities similar to those described in Mag-null 
or B4galnt1-null mutant mice. Mag-null mice display delayed 
myelination and frequent myelin structural abnormalities 
(56, 57). Similar alterations were found in B4galnt1-null mice, 
which are considered completely devoid of complex ganglio-
sides (58, 59). However, myelin vacuolation was not described 
in such mutants. Therefore, other factors, in addition to 
MAG–ganglioside disruption, may be involved in NA-induced 
vacuolation. Furthermore, temporal factors should also be 
considered, as they might contribute to those differences: in 
Mag-null and B4galnt1-null mutants, the MAG–ganglioside 
interaction is permanently disrupted, while in NA-induced 
vacuolation, the disruption is transient. Similar intramyelinic 
vacuolation has been found in mitochondrial encephalopathies 
as Kearns–Sayre syndrome (60), in Canavan’s disease (61), in 
vitamin B12-deficient animals (62), in toxin-induced injuries 
(63), and in retroviral infections (64). Although in some of these 
myelinopathies the authors have placed the oligodendrocytes in 
the center of the disease (60, 65, 66), the mechanisms of vacu-
olation remain speculative in most of them.
The origin of several myelin pathologies, such as multiple 
sclerosis, acute disseminated encephalomyelitis, and acute 
hemorrhagic leukoencephalitis, has been related to neuroin-
flammatory processes (67). Mostly autoimmune demyelinat-
ing diseases are accompanied by inflammation of the CNS 
(67). The well-established notion that multiple sclerosis is an 
autoimmune and inflammatory disease has recently evolved 
toward the idea that it is a neurodegenerative disease with an 
inflammatory component (68, 69). On the other hand, chronic 
metabolic or mitochondrial encephalopathies are essentially 
devoid of neuroinflammatory component (70). In NA-injected 
rats, a neuroinflammatory process with an important infiltra-
tion of immunocompetent cells occurs (24). In order to explore 
whether the neuroinflammatory reaction induced by NA is 
the cause of myelin vacuolation, the anaphylatoxin C5a was 
ICV injected in rats. C5a is produced by the proteolysis of C5 
FigUre 6 | apoptosis detected by caspase-3 immunostaining 1 day after the intracerebroventricular injection of neuraminidase (na).  
(a,B) Caspase-3-positive cells were found in the lateral ventricle subventricular zone, where apoptosis occurs as part of the neurogenesis process. Staining was 
also evident in the palatine tonsil [inset in panel (B)] used as a positive control. (c,D) No caspase-3-positive cells could be detected either in the stria medullaris (SM) 
or in the ventricular wall, where ependymal cells are damaged by NA. Ependymal cells were negative since they die by necrosis. Arrows point to vacuoles in SM. All 
sections were counterstained with hematoxylin. CC, corpus callosum; Ep, ependyma. Magnification bar = 50 μm in panel (a), 30 μm in panel (B), and 50 μm in 
panels (c,D).
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component of complement and functions as an inflammatory 
signaling molecule, thereby inducing the activation of mast 
cells, basophils, and neutrophils which release histamine and 
pro-inflammatory cytokines (71). In addition, C5a displays 
a chemotactic function, thereby promoting the recruitment 
of neutrophils and macrophages to the inflammatory focus 
(72–74). In our study, ICV injection of C5a induced a neu-
roinflammatory reaction similar to that provoked by the ICV 
injection of NA. However, the vacuolation of axonal bundles 
observed in NA-treated rats was absent in C5a-injected rats, in 
spite of the evident neuroinflammatory reaction. These results 
suggest that the neuroinflammation process, including inva-
sion of ventricles, periventricular areas, meninges, and choroid 
plexus by immunocompetent cells, is not the cause of the myelin 
vacuolation events observed in NA-injected rats.
The function of the complement system in myelinopathies 
(including demyelination) has been a matter of debate (26). 
While a protective role of complement in demyelination has 
been reported (27, 28), other authors suggest that the comple-
ment does not participate in demyelination (35), or have a role 
in immune-mediated myelin diseases (29–34). In the classical 
pathway of the complement, activated C1 induces the cleavage of 
C4 to form the anaphylatoxin C4a (75). Upregulation of C4A has 
been described in the CSF of a fulminant case of multiple scle-
rosis (76). In another study, two factors involved in complement 
activation, clusterin and C3, were identified in the CSF of several 
patients of multiple sclerosis (77).
To assess the role of the complement system, and specifically 
of MAC, in NA-induced myelin vacuolation, we pursued the 
immunolocalization of C5b9 on vacuolated myelin bundles 
and evaluated NA-induced vacuolation under situations of 
partial inhibition or complete blockade of MAC formation. 
Immunostaining with anti-C5b9 (MAC) did not label the 
damaged axonal bundles; however, MAC labeling was evident 
in damaged ependymal cells (25). Partial inhibition of MAC 
formation was achieved in vivo by blocking C5 activation with 
a monoclonal antibody administered systemically as well as 
ICV (25, 78, 79). C5-inhibited rats injected with NA displayed 
the same degree of myelin vacuolation as non-inhibited rats. 
The damage provoked by NA under C5 inhibition could have 
several explanations: (i) NA activates the complement system 
downstream of C5 in the proteolytic cascade; this is unlikely 
because in vitro experiments showed that NA-induced activa-
tion of complement at the level of C3 and generates iC3b in 
human serum (39); (ii) other mechanisms, independent of 
complement, could account for the vacuolation of the myelin. 
A second model of in vivo MAC deficiency is provided by C6 
mutant rats, which bear a spontaneous deletion in the C6 gene 
(40, 80), preventing C6 synthesis and hence blocking forma-
tion of MAC and complement-mediated cell lysis (81, 82). In 
FigUre 7 | analysis of the role of the complement system in neuraminidase (na)-induced myelin vacuolation. (a,B) The formation of membrane attack 
complex deposits was evaluated by immunohistochemistry using a specific anti-C5b9 antibody. Labeling with this marker was evident in swollen lymph node used a 
positive control [inset in panel (B)] but completely absent in vacuolated SM. Ependymal cells were absent in this section due to NA treatment, and therefore, no 
labeling with anti-C5b9 was observed. (B) Higher magnification of an equivalent area squared in panel (a). (c–e) Rats were intracerebroventricular (ICV) injected 
with the anaphylatoxin C5a to generate a neuroinflammation process similar to that induced by NA. Seven days after C5a injection, the axonal bundles usually 
affected by NA injection, that is the SM (c,D) and the fimbria (e), displayed no abnormalities. (F,g) The complement system was inhibited by systemic and ICV 
injection of a functional monoclonal antibody against C5. Animals treated for complement inhibition were then subjected to a single ICV injection of NA. Myelin 
vacuolation observed in the SM was similar in anti-C5-treated and non-treated rats, indicating that complement blockade does not affect the NA-induced 
vacuolation process [arrows in panel (g) point to the vacuoles]. (h,i) Rats lacking the C6 component of the complement system were injected with NA to evaluate 
myelin vacuolation. The vacuolar lesions observed in the SM of these rats were similar to those of wild-type rats (not shown). Sections in panels (c–i) were stained 
with hematoxylin and eosin (H–E). SM, stria medullaris. Magnification bar = 200 μm in panel (a), 15 μm in panel (B), 200 μm in panel (c), 20 μm in panel (D), 50 μm 
in panel (e), 200 μm in panel (F), 25 μm in panel (g), 200 μm in panel (h), and 50 μm in panel (i).
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C6−/− rats, the degree of myelin vacuolation after NA injection 
was similar to that of wild-type rats. Since MAC formation is 
completely precluded in C6 mutant rats (and was not detected 
by immunohistochemistry), these results lead us to conclude 
that the lytic pathway of complement does not participate in the 
myelin damage caused by NA.
Some viruses associated with subsequent myelin disorders 
contain NA in their coats, as is the case for influenza virus 
(83), parainfluenza virus (84), mumps virus (85), and measles 
virus (86). Acute disseminated encephalomyelitis and acute 
haemorrhagic leucoencephalitis are inflammatory demyelinat-
ing diseases that arise within 3 weeks of an infection with these 
viruses (87–90), among other viruses and bacteria (67). Subacute 
sclerosing panencephalitis, also called measles encephalitis, is 
a neuroinflammatory disease triggered by measles virus (91). 
Perivascular inflammation, gliosis in white matter, and irregular 
loss of myelin and axons in white matter are the hallmarks of 
this disease (67). The presence of NA in the virus coat confers a 
higher degree of virulence (92, 93). In the event of a brain infec-
tion by any of these NA-bearing viruses, NA could disturb the 
axon–myelin stability as seen in our NA-injected rats. Thus, NA 
might contribute to the myelin disorders associated with certain 
viral infections.
In summary, a single ICV injection of NA in rats induces a 
transient myelin vacuolation that consistently affects the SM, 
the optic chiasm, and the fimbria. The location of the vacuoles 
between the myelin sheath and the axonal plasma membrane 
suggests a disturbance of the interaction between the innermost 
wrap of myelin and the axon membrane. A possible disruption 
(provoked by NA) of the interaction between MAG and ganglio-
sides at this level is hypothesized. The myelin damage observed 
seems to be moderate, as it reverts in 2 weeks, and is not accom-
panied by cell loss (the oligodendrocyte population within the 
affected tracts remains unaltered, and no neurodegeneration is 
detected in the related neuronal nuclei). The possibility that the 
cause of the vacuolation process could be the neuroinflammation 
occurring upon NA injection was ruled out based on the results 
obtained with the ICV injection of anaphylatoxin C5a. Finally, 
various forms of evidence lead us to discard the participation of 
the complement system in the process of vacuolation induced 
by NA. Therefore, the direct sialidase action of NA on myelin 
sheaths seems to be the most probable cause of vacuolation. The 
knowledge of the mechanisms underlying the myelin disorders 
caused by NA-bearing pathogens of the CNS may help to design 
more effective therapeutic strategies.
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